Following representations made by Community Pharmacy England on behalf of community pharmacy contractors, the Department of Health and Social Care (DHSC) has retrospectively adjusted the reimbursement prices for all strengths of Latuda® (lurasidone) tablets dispensed in April 2024. On 1 April 2024, there was an increase in the NHS list prices of Latuda® (all strengths) manufactured
Read moreDepartment of Health and Social Care (DHSC) has issued a medicine supply notification for Cefalexin 500mg tablets. MSN/2024/083 Tier 2 – medium impact Date of issue: 6th August 2024 Cefalexin 500mg tablets are out of stock until mid-September 2024. Cefalexin 500mg capsules remain available and can support an uplift in demand. Alternative cefalexin preparations remain
Read moreFollowing representations from Community Pharmacy England on behalf of community pharmacy contractors, the Department of Health and Social Care (DHSC) has redetermined the reimbursement prices for EpiPen® and Jext® (adrenaline) preparations dispensed in July 2024. On 1 July 2024, there was an increase in the NHS list prices of EpiPen® and Jext® preparations manufactured by
Read moreClass 4 Medicines Defect Information: Omeprazole products (Sandoz Limited) Drug alert number: EL (24)A/34 Date issued: 07 August 2024 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 4 medicines defect information notice for: Omeprazole products (Sandoz Limited) Company name: Sandoz Limited Product name: Omeprazole 10mg gastro-resistant capsules, PL 04416/0651 SNOMED Code: 3753411000001102
Read moreFollowing representations from Community Pharmacy England, the Department of Health and Social Care (DHSC) has confirmed that the following products have been granted upward retrospective pricing adjustments due to out of date product and/or pricing information held on NHS dictionary of medicines and devices (dm+d). A change to the reimbursement will apply to prescriptions dispensed
Read moreDepartment of Health and Social Care (DHSC) has issued a medicine supply notification for Ramipril 2.5mg tablets. MSN/2024/082 Tier 2 – medium impact Date of issue: 6th August 2024 Ramipril 2.5mg tablets are anticipated to be out of stock from mid-August until late-October 2024. Ramipril 2.5mg capsules remain available and can support a full uplift
Read moreIn response to a significant ongoing disruption to the supply of Cefalexin 500mg tablets, a Serious Shortage Protocol (SSP) has been issued by the Department of Health and Social Care (DHSC). Effective today 6 August 2024, SSP072 provides that for every Cefalexin 500mg tablet originally prescribed one Cefalexin 500mg capsule must be supplied. SSP072, authorised by the Secretary
Read moreIn response to a significant ongoing disruption to the supply of Ramipril 2.5mg tablets, a Serious Shortage Protocol (SSP) has been issued by the Department of Health and Social Care (DHSC). Effective today 6 August 2024, SSP071 provides that for every Ramipril 2.5mg tablet originally prescribed one Ramipril 2.5mg capsule must be supplied. SSP071, authorised by the Secretary
Read moreProtests and violent disorder are affecting some towns and cities across England and this may have an impact on the ability of community pharmacies to operate. If your pharmacy is in an area which is being affected by protests, follow any guidance being provided by the police or local government to protect yourself, staff, patients
Read moreClass 3 Medicines Recall: Atomoxetine 10mg, 18mg, 25mg, 40mg, 60mg, 80mg, 100mg Hard Capsules (Accord Healthcare Ltd) Drug alert number: EL (24)A/33 MDR number: MDR 113-05/24 Date issued: 30 July 2024 The Medicines and Health products Regulatory Agency (MHRA) has issued a class 3 medicines recall for: Atomoxetine 10mg, 18mg, 25mg, 40mg, 60mg, 80mg, 100mg Hard
Read more
